Request a Proposal
Welcome to Rapport, containing tips, truths, news and views, blogs, tweets, articles and films covering a range of topics currently affecting Research Partnership and the pharma market research world
  • Posted by Pei Li Teh & Colin Tan
  • October 22, 2019
  • Events

Real world evidence research breakfast seminar

Real world evidence research breakfast seminar

We were delighted to attend and present a paper at the Tech Observer event in Singapore earlier this month

APAC Director Pei Li Teh, and Research Manager, Colin Tan, attended the event. Pei Li presented the paper ‘Inhale, exhale: How using real world data helped asthma patients breathe easier across Asia’. In her paper she demonstrated how published real world data research provided pharma companies with an in-depth understanding of asthma patients’ across Asia. The data provided the healthcare community with a tool to supply tailored communications supporting different patient types, instead of a ‘one size fits all’ approach.

read more »

  • Posted by Pei Li Teh
  • October 21, 2019
  • News

Research Partnership welcomes Jeanne Penn

Research Partnership welcomes Jeanne Penn

We are delighted to announce that Jeanne Penn has joined the Singapore office as a Senior Research Executive.

Jeanne previously worked at Cello Health Insight in New York City on the qualitative team, where she was involved in all parts of the research process, from writing proposals to delivering reports. She’s worked in various therapy areas, and has a particular interest in rare diseases and mental health. In a prior role, she co-led the first Diversity & Inclusion initiative and was awarded the Young Professionals Grant to attend the Qualitative Research Consultants Association (QRCA) conference. Jeanne graduated from Hamilton College, and interned at Hall & Partners where she was first introduced to healthcare market research.

read more »

How we used a hybrid qual-quant methodology to assess the market opportunity for a new rare disease treatment

How we used a hybrid qual-quant methodology to assess the market opportunity for a new rare disease treatment

Our client is a recently established independent biopharmaceutical company specialising in small molecule development. They were developing a new oral compound for the treatment of a rare genetic disease for which the standard treatment is administered intravenously, however a large proportion of patients receive monitoring only or remain undiagnosed. Their objective was to successfully launch their product in order to provide clinically meaningful benefits to patients and contribute to the overall growth of their business.

read more »

How facial analysis was used to evaluate the emotional impact of a disease promotion campaign

Our client had developed a visual and emotion-invoking, online disease awareness campaign aimed at challenging physicians’ current perceptions of treatment. Research was required to understand physicians’ reactions to the campaign (rational and emotional) and whether it would have the desired effect of increasing use of their treatment in the future, to help encourage the client’s local operating companies to adopt and roll out the campaign. 
 

read more »

  • Posted by Julie Denny
  • August 31, 2017
  • Webinars

Webcast: Capturing the “moments-of-truth” using online communities and bulletin boards

Webcast: Capturing the “moments-of-truth” using online communities and bulletin boards

Download this complimentary webcast in which market research consultants  market research consultants Jenny Redfearn and Melinda Shorrdemonstrate how, with careful set-up and management, online communities and bulletin boards can be excellent methods of capturing truer, deeper insights.   

read more »